Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Wica Clinical Trials Consultancy AB
AB
Active
Org 5594672312
Palmbladsvägen 2, 112 58
Stockholm
Business and other management consultancy activities
· NACE 7020
Est. 2024
1 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
Wica Clinical Trials Consultancy AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
1M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
394
701
Staff expenses
−30
−105
EBITDA
330
556
Depreciation & amort.
—
−70
EBIT
330
486
Net financials
—
0
Profit before tax
330
487
Tax
−69
−100
Net profit
262
386
Balance sheet
SEK thousands
Item
2024
2025
Total assets
389
578
Equity
287
493
Long-term debt
—
—
Short-term debt
103
85
Total debt
103
85
Financial ratios
5-year trend
EBITDA margin
79.3%
This company
15.8%
Market median
+402% vs market
2024
2025
Equity ratio
85.3%
This company
38.2%
Market median
+123% vs market
2024
2025
Return on equity
78.4%
This company
18.4%
Market median
+326% vs market
2024
2025
Net profit margin
55.1%
This company
8.1%
Market median
+580% vs market
2024
2025
Asset turnover
1.21×
This company
1.12×
Market median
+8% vs market
2024
2025
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-09 – 2024-12-31
View
PDF
More on Wica Clinical Trials Consultancy AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network